Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$15.16 - $18.97 $1.42 Million - $1.78 Million
-93,808 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.12 - $20.9 $1.23 Million - $1.96 Million
93,808 New
93,808 $1.68 Million
Q2 2020

Aug 14, 2020

SELL
$12.0 - $16.13 $960,000 - $1.29 Million
-80,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$11.84 - $25.52 $651,200 - $1.4 Million
55,000 Added 220.0%
80,000 $1.08 Million
Q3 2019

Nov 14, 2019

BUY
$18.41 - $28.0 $460,250 - $700,000
25,000 New
25,000 $480,000
Q3 2018

Nov 14, 2018

SELL
$56.15 - $73.9 $2.19 Million - $2.88 Million
-39,000 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$47.85 - $70.45 $1.87 Million - $2.75 Million
39,000 New
39,000 $2.64 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.